SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000927016-02-001328
Filing Date
2002-03-06
Accepted
2002-03-06 00:00:00
Documents
6
Period of Report
2002-03-05
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.txt 8-K 7715
3 PURCHASE AGREEMENT dex41.txt EX-4.1 72856
4 CONVERTIBLE NOTE dex42.txt EX-4.2 73712
5 PURCHASE WARRANT dex43.txt EX-4.3 40418
6 REGISTRATION RIGHTS AGREEMENT dex44.txt EX-4.4 44316
7 PRESS RELEASE dex991.txt EX-99.1 2873
  Complete submission text file 0000927016-02-001328.txt   244076
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-10824 | Film No.: 02567769
SIC: 2835 In Vitro & In Vivo Diagnostic Substances